Solvay Pharmaceuticals, a US subsidiary of the Belgian drugmaker, has launched a new multi-media web site, www.isitlowt.com, to educate men and health care professionals about low testosterone. "Low T, "also known as hypogonadism, is a condition where a man's body does not produce enough testosterone. An estimated 90% of the more than 13 million American men who suffer from Low T remain untreated, the company notes.
"There is a lack of awareness on low testosterone in this country, and many especially do not realize that low testosterone levels can be associated with other serious medical conditions, such as type 2 diabetes and obesity," says Chad Ritenour, assistant professor and director of Men's Health Center for the Department of Urology at Emory University, Atlanta. "More tools and information are needed to help men and their partners recognize the symptoms of low testosterone and initiate a conversation with their physician about having their testosterone levels checked through a simple blood test," he said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze